Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Retatrutide is an investigational triple receptor agonist developed by Eli Lilly that simultaneously targets three distinct hormonal receptors involved in energy regulation and metabolic control
Results Disclaimer This content is for informational purposes only and does not provide medical advice, diagnosis, or treatment
PlexusDx Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and carries the same active pharmaceutical compound as name-brand alternatives, but without the markup associated with branded manufacturing and distribution
LillyDirect (Zepbound) and NovoCare (Wegovy) sell directly to patients without requiring insurance
lack FDA approval for safety, quality, or efficacy
